Patterns of Combined Prenatal Supplement Use and Associations with Birth Outcomes and Early Infant Growth: A Multicenter Prospective Mother–Infant Cohort Study in China
5 affiliations
- 1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
- 2Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xianxia Road, Shanghai 200336, China
- 3School of Basic Medicine Sciences, Gannan Medical University, Ganzhou 341000, China
- 4Hainan International Medical Center, Shanghai Jiao Tong University School of Medicine, Qionghai 571400, China
- 5Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Abstract
Background: Women often use several prenatal supplements together, yet most studies evaluate products one at a time. Objective: To identify longitudinal patterns of combined prenatal supplement use and assess their associations with cesarean delivery, birth size, jaundice, and early infant growth. Methods: This multicenter cohort included 1758 mother–infant pairs from 16 provinces in China. Supplement use was reported once in the baseline questionnaire: on or before delivery for 876 women (median gestational age 38.57 weeks) and after delivery for 809. For each of seven supplements, use frequency was reported once, and participants indicated the pregnancy periods during which the supplement was used. One frequency was assigned to every period endorsed from preconception through the third trimester, giving 28 indicators for latent class analysis. Associations were estimated in exploratory multivariable models, with Benjamini–Hochberg correction within outcome families. Results: Six patterns were identified. They differ in product combination, endorsed periods, and one recorded frequency per product, and are not ordered by dose (C6 (low use), 25.7%; C4 (all-supplement high-frequency), 7.0%). Membership differed by region, parity, and pregnancy complications. Compared with C6, mid-late high-frequency core use (C5) was nominally associated with lower odds of cesarean delivery (adjusted OR 0.72, 95% CI 0.53–0.99). Persistent multi-supplement high-frequency use (C3) and all-supplement high-frequency use (C4) were nominally associated with higher odds of physiological jaundice recorded at the 40–60-day follow-up (1.65, 1.00–2.70 and 1.86, 1.04–3.27), and C4 with shorter birth length (adjusted β −0.46 cm, 95% CI −0.81 to −0.10). These associations did not remain significant after within-family correction. Macrosomia, infant eczema, and gains in length and weight showed no association. Greater head-circumference gain in mid-late moderate core use (C1) remained significant after correction (adjusted β 0.87 cm, 95% CI 0.34–1.40; q = 0.019) among 513 infants in the adjusted analysis. Conclusions: Supplement use clustered into six patterns of timing and reported frequency. The associations are observational and do not show that changing a supplement regimen would change these endpoints.
Related
- Associations of baseline levels, cumulative exposure, and two-wave patterns of the combined triglyceride-glucose index and frailty index with progression from cardiovascular-kidney-metabolic syndrome stages 0-2 to stages 3-4 and stage 4: a prospective cohort study from CHARLS.
- Timdarpacept (IMM01) combined with azacitidine (AZA) as first-line therapy in adults with higher risk chronic myelomonocytic leukemia (CMML): results from a prospective, multicenter, phase II study.
- Associations of cumulative exposure and dynamic trajectories of the combined atherogenic-frailty index with incident cardiometabolic multimorbidity: a prospective cohort study.
- Trends, patterns, and determinants of dietary supplement use in patients with Type 2 Diabetes Melitus
- The associations between healthful and unhealthful plant-based dietary patterns and all-cause mortality among older Chinese adults with data-adapted early-stage cardiovascular-kidney-metabolic syndrome (stages 0–2): a prospective cohort study from the CLHLS
BibTeX
@article{zhang2026patterns,
title = {{Patterns of Combined Prenatal Supplement Use and Associations with Birth Outcomes and Early Infant Growth: A Multicenter Prospective Mother–Infant Cohort Study in China}},
author = {Haoquan Zhang and Zheng Bian and Yongyi Zhang and Yuchen Wu and Zihan Xiong and Ahenaer Teliewubieerde and Weijie Cai and Siliang Duan and Yuanyuan Yan and Hui Wang},
journal = {Nutrients},
year = {2026},
month = nov,
doi = {10.3390/nu18213649},
url = {https://www.mdpi.com/2072-6643/18/21/3649},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Patterns of Combined Prenatal Supplement Use and Associations with Birth Outcomes and Early Infant Growth: A Multicenter Prospective Mother–Infant Cohort Study in China
AU - Haoquan Zhang
AU - Zheng Bian
AU - Yongyi Zhang
AU - Yuchen Wu
AU - Zihan Xiong
AU - Ahenaer Teliewubieerde
AU - Weijie Cai
AU - Siliang Duan
AU - Yuanyuan Yan
AU - Hui Wang
PY - 2026
DA - 2026/11/02
JO - Nutrients
DO - 10.3390/nu18213649
UR - https://www.mdpi.com/2072-6643/18/21/3649
AB - Background: Women often use several prenatal supplements together, yet most studies evaluate products one at a time. Objective: To identify longitudinal patterns of combined prenatal supplement use and assess their associations with cesarean delivery, birth size, jaundice, and early infant growth. Methods: This multicenter cohort included 1758 mother–infant pairs from 16 provinces in China. Supplement use was reported once in the baseline questionnaire: on or before delivery for 876 women (median gestational age 38.57 weeks) and after delivery for 809. For each of seven supplements, use frequency was reported once, and participants indicated the pregnancy periods during which the supplement was used. One frequency was assigned to every period endorsed from preconception through the third trimester, giving 28 indicators for latent class analysis. Associations were estimated in exploratory multivariable models, with Benjamini–Hochberg correction within outcome families. Results: Six patterns were identified. They differ in product combination, endorsed periods, and one recorded frequency per product, and are not ordered by dose (C6 (low use), 25.7%; C4 (all-supplement high-frequency), 7.0%). Membership differed by region, parity, and pregnancy complications. Compared with C6, mid-late high-frequency core use (C5) was nominally associated with lower odds of cesarean delivery (adjusted OR 0.72, 95% CI 0.53–0.99). Persistent multi-supplement high-frequency use (C3) and all-supplement high-frequency use (C4) were nominally associated with higher odds of physiological jaundice recorded at the 40–60-day follow-up (1.65, 1.00–2.70 and 1.86, 1.04–3.27), and C4 with shorter birth length (adjusted β −0.46 cm, 95% CI −0.81 to −0.10). These associations did not remain significant after within-family correction. Macrosomia, infant eczema, and gains in length and weight showed no association. Greater head-circumference gain in mid-late moderate core use (C1) remained significant after correction (adjusted β 0.87 cm, 95% CI 0.34–1.40; q = 0.019) among 513 infants in the adjusted analysis. Conclusions: Supplement use clustered into six patterns of timing and reported frequency. The associations are observational and do not show that changing a supplement regimen would change these endpoints.
SN - 2072-6643
ER -